Active Ingredient: Lanreotide
Treatment of thyrotropic adenomas when the circulating level of thyroid stimulating hormone remains inappropriately high after surgery and/or radiotherapy.
For this indication, competent medicine agencies globally authorize below treatments:
For:
Intramuscular
30 - 30 mg
From 30 To 30 mg once every 14 day(s)
Initially, one intramuscular injection should be given every 14 days.
In the case of an insufficient response, as judged by the levels of thyroid hormone and TSH, the frequency of injection may be increased to one every 10 days. Continued treatment should be guided by periodic measurement of thyroid hormone and TSH.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
